RP

Rafi Perveez

Active Director Director DIN 01278653
DIN 01278653 First appointment Sep 2003 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2003
Shareholding value •••• Premium profile

About Rafi Perveez

Data last updated:

Rafi Perveez is a Director at Gentec Medical Private Limited (since 2003). The company operates in Healthcare. Gentec Medical Private Limited reported revenue of ₹4.21 Cr (FY 2025).

DIN 01278653
Primary Designation Director
Industry Healthcare
First Appointment 03 Sep 2003
Oldest Company Age 23 yrs
Largest company Gentec Medical Private Limited · ₹4.21 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gentec Medical Private Limited U05190KA2003PTC032493
Director03 Sep 20032003₹4.21 Cr (FY 2025)Active

Board colleagues of Rafi Perveez

NameDINCompanyDesignation
Hajeera Khatoon02879653Gentec Medical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gentec Medical Private Limited
Premium access

Shareholding and investment profile for Rafi Perveez

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rafi Perveez

Rafi Perveez currently holds 1 directorship: Gentec Medical Private Limited (Director, since 03 Sep 2003, revenue ₹4.21 Cr (FY 2025)).

Rafi Perveez was first appointed on 03 Sep 2003 as Director at Gentec Medical Private Limited.

The current boards of Rafi Perveez's companies include Hajeera Khatoon (Gentec Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available